
Portland Research Site Marks 50 Years of Alzheimer’s Breakthroughs
Since 1976, Headlands Research - Summit Portland has operated as a cornerstone of neurological advancement, participating in clinical trials for every class of FDA-approved Alzheimer’s medication since 1993. The organization is now celebrating its 50th anniversary, marking five decades of contributions to psychiatric and central nervous system research.






















